ABBOTT INDIA
|
The Current P/E Ratio of ABBOTT INDIA is 38.26.
| Share Price | ₹28,008.8 | Aug 11,2026 |
| Market Cap | ₹59,378.7 Cr | |
| Earnings-TTM | ₹1,552.0 Cr | TTM-Standalone Results |
| Price/Earnings | 38.26x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ABBOTT INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹59,378.7 Cr] as on Aug 11,2026
(/) Earnings [ ₹1,552.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 38.26x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay 38.26 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ABBOTT INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ABBOTT INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of ABBOTT INDIA
PE Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 45.17x.
- ABBOTT INDIA 's operated at median p/e ratio of 47.09x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2023 at 49.43x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2026 of 35.49x.
How does ABBOTT INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ABBOTT INDIA | 1,552.02 | 38.26 | 59,378.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 38.24 | 465,471.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 77.48 | 226,631.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 85.88 | 185,157.0 |
| CIPLA LTD | 3,364.84 | 35.10 | 118,108.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 31.74 | 100,578.0 |
| MANKIND PHARMA LTD | 2,055.11 | 48.73 | 100,152.0 |
| LUPIN LTD | 5,551.01 | 18.76 | 104,158.0 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 26.20 | 117,705.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.45 | 94,477.0 |
| LAURUS LABS LTD | 1,090.76 | 92.14 | 100,498.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ABBOTT INDIA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.76x |
| Max industry PE | 92.14x |
| Median industry PE | 38.24x |
| Average industry PE | 47.09x |
You may also like the below Video Courses